Harvard Bioscience Inc
NASDAQ:HBIO
Gross Margin
Harvard Bioscience Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | US |
| Market Cap | 137.2m USD |
| Gross Margin |
59%
|
| Country | US |
| Market Cap | 222.9B USD |
| Gross Margin |
40%
|
| Country | US |
| Market Cap | 194.6B USD |
| Gross Margin |
58%
|
| Country | US |
| Market Cap | 44.1B USD |
| Gross Margin |
51%
|
| Country | US |
| Market Cap | 41.8B USD |
| Gross Margin |
35%
|
| Country | CH |
| Market Cap | 37B CHF |
| Gross Margin |
36%
|
| Country | KR |
| Market Cap | 53.4T KRW |
| Gross Margin |
48%
|
| Country | US |
| Market Cap | 31.6B USD |
| Gross Margin |
59%
|
| Country | IE |
| Market Cap | 26.5B USD |
| Gross Margin |
30%
|
| Country | US |
| Market Cap | 24.2B USD |
| Gross Margin |
37%
|
| Country | US |
| Market Cap | 20B USD |
| Gross Margin |
60%
|
Profitability Report
View the profitability report to see the full profitability analysis for Harvard Bioscience Inc.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Harvard Bioscience Inc's most recent financial statements, the company has Gross Margin of 58.5%.
You don't have any saved screeners yet
